| |
Survivors |
Non-survivors |
P Value |
| (N = 24) |
(N = 10) |
| Age (years) |
52 ± 14 |
52 ± 19 |
NS |
| Female (%) |
13 (54) |
6 (60) |
NS |
| Caucasian (%) |
23 (96) |
8 (80) |
NS |
| Diabetes Mellitus (%) |
5 (21) |
1 (10) |
NS |
| Hypertension (%) |
12 (50) |
4 (40) |
NS |
| Cardiac disease (%) |
7 (29) |
4 (40) |
NS |
| Malignancy (%) |
4 (17) |
3 (30) |
NS |
| Sepsis (%) |
9 (38) |
5 (50) |
NS |
| Apache II |
22.3 ± 10.5 |
31.8 ± 5.3 |
0.001 |
| Baseline SCr (mean, mg/dL) |
1.0 ± 0.37 |
0.86 ± 0.17 |
NS |
| Days from Diagnosis of AKI to Sample Collection (mean) |
3.0 ± 1.5 |
4.8 ± 3.3 |
NS |
| Need for RRT |
58% |
40% |
NS |
| Etiology of AKI (%) |
|
|
|
| Sepsis |
8 (33.3) |
5 (50) |
|
| Ischemia |
5 (20.8) |
3 (30) |
|
| Multifactorial |
7 (29.2) |
2 (20) |
|
| Nephrotoxin |
2 (8.3) |
0 |
|
| Rhabdomyolysis |
2 (8.3) |
0 |
|
| AKI – Acute Kidney Injury |
|
